Literature DB >> 35554908

Detection of SARS-CoV-2 by Mass Spectrometry.

Petra Wandernoth1, Katharina Kriegsmann2, Jörg Kriegsmann1,3,4, Mark Kriegsmann5,6.   

Abstract

Amplification of viral ribonucleic acid by real-time reverse transcriptase polymerase chain reaction is the gold standard to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, alternative reliable, fast, and cost-effective methods for the detection of SARS-CoV-2 are still needed. In this chapter, the mass spectrometry-based detection of amplified polymerase chain reaction products of SARS-CoV-2 genes from oral or nasopharyngeal swabs is described. The respective SARS-CoV-2 test has previously been shown to meet standard quality criteria and was therefore approved by the authorities in Europe and the USA.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  COVID-19; Mass Spectrometry; MassARRAY; SARS-CoV-2

Mesh:

Substances:

Year:  2022        PMID: 35554908     DOI: 10.1007/978-1-0716-2111-0_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Detection of HPV subtypes by mass spectrometry in FFPE tissue specimens: a reliable tool for routine diagnostics.

Authors:  Mark Kriegsmann; Petra Wandernoth; Katharina Lisenko; Rita Casadonte; Rémi Longuespée; Norbert Arens; Jörg Kriegsmann
Journal:  J Clin Pathol       Date:  2016-10-08       Impact factor: 3.411

Review 2.  Matrix-assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiology: An updating review.

Authors:  S Angeletti; M Ciccozzi
Journal:  Infect Genet Evol       Date:  2019-10-13       Impact factor: 3.342

Review 3.  Emerging role of clinical mass spectrometry in pathology.

Authors:  Angela W S Fung; Vijithan Sugumar; Annie He Ren; Vathany Kulasingam
Journal:  J Clin Pathol       Date:  2019-11-05       Impact factor: 3.411

4.  Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Authors:  Wendy De Roock; Bart Claes; David Bernasconi; Jef De Schutter; Bart Biesmans; George Fountzilas; Konstantine T Kalogeras; Vassiliki Kotoula; Demetris Papamichael; Pierre Laurent-Puig; Frédérique Penault-Llorca; Philippe Rougier; Bruno Vincenzi; Daniele Santini; Giuseppe Tonini; Federico Cappuzzo; Milo Frattini; Francesca Molinari; Piercarlo Saletti; Sara De Dosso; Miriam Martini; Alberto Bardelli; Salvatore Siena; Andrea Sartore-Bianchi; Josep Tabernero; Teresa Macarulla; Frédéric Di Fiore; Alice Oden Gangloff; Fortunato Ciardiello; Per Pfeiffer; Camilla Qvortrup; Tine Plato Hansen; Eric Van Cutsem; Hubert Piessevaux; Diether Lambrechts; Mauro Delorenzi; Sabine Tejpar
Journal:  Lancet Oncol       Date:  2010-07-08       Impact factor: 41.316

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  A blueprint for academic laboratories to produce SARS-CoV-2 quantitative RT-PCR test kits.

Authors:  Samantha J Mascuch; Sara Fakhretaha-Aval; Jessica C Bowman; Minh Thu H Ma; Gwendell Thomas; Bettina Bommarius; Chieri Ito; Liangjun Zhao; Gary P Newnam; Kavita R Matange; Hem R Thapa; Brett Barlow; Rebecca K Donegan; Nguyet A Nguyen; Emily G Saccuzzo; Chiamaka T Obianyor; Suneesh C Karunakaran; Pamela Pollet; Brooke Rothschild-Mancinelli; Santi Mestre-Fos; Rebecca Guth-Metzler; Anton V Bryksin; Anton S Petrov; Mallory Hazell; Carolyn B Ibberson; Petar I Penev; Robert G Mannino; Wilbur A Lam; Andrés J Garcia; Julia Kubanek; Vinayak Agarwal; Nicholas V Hud; Jennifer B Glass; Loren Dean Williams; Raquel L Lieberman
Journal:  J Biol Chem       Date:  2020-09-03       Impact factor: 5.157

7.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.